Literature DB >> 22124151

Oestrogen upregulates L-type Ca²⁺ channels via oestrogen-receptor- by a regional genomic mechanism in female rabbit hearts.

Xiaoyan Yang1, Guojun Chen, Rita Papp, Donald B Defranco, Fandian Zeng, Guy Salama.   

Abstract

In type-2 long QT (LQT2), adult women and adolescent boys have a higher risk of lethal arrhythmias, called Torsades de pointes (TdP), compared to the opposite sex. In rabbit hearts, similar sex- and age-dependent TdP risks were attributed to higher expression levels of L-type Ca(2+) channels and Na(+)-Ca(2+) exchanger, at the base of the female epicardium. Here, the effects of oestrogen and progesterone are investigated to elucidate the mechanisms whereby I(Ca,L) density is upregulated in adult female rabbit hearts. I(Ca,L) density was measured by the whole-cell patch-clamp technique on days 0-3 in cardiomyocytes isolated from the base and apex of adult female epicardium. Peak I(Ca,L) was 28% higher at the base than apex (P < 0.01) and decreased gradually (days 0-3), becoming similar to apex myocytes, which had stable currents for 3 days. Incubation with oestrogen (E2, 0.1-1.0 nm) increased I(Ca,L) (∼2-fold) in female base but not endo-, apex or male myocytes. Progesterone (0.1-10 μm) had no effect at base myocytes. An agonist of the α- (PPT, 5 nm) but not the β- (DPN, 5 nm) subtype oestrogen receptor (ERα/ERβ) upregulated I(Ca,L) like E2. Western blots detected similar levels of ERα and ERβ in male and female hearts at the base and apex. E2 increased Cav1.2α (immunocytochemistry) and mRNA (RT-PCR) levels but did not change I(Ca,L) kinetics. I(Ca,L) upregulation by E2 was suppressed by the ER antagonist ICI 182,780 (10 μm) or by inhibition of transcription (actinomycin D, 4 μm) or protein biosynthesis (cycloheximide, 70 μm). Therefore, E2 upregulates I(Ca,L) by a regional genomic mechanism involving ERα which is a known determinant of sex differences in TdP risk in LQT2.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22124151      PMCID: PMC3379696          DOI: 10.1113/jphysiol.2011.219501

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  52 in total

Review 1.  Long QT syndrome.

Authors:  G M Vincent
Journal:  Cardiol Clin       Date:  2000-05       Impact factor: 2.213

2.  A new promoter for alpha1C subunit of human L-type cardiac calcium channel Ca(V)1.2.

Authors:  Bosong Dai; Nehad Saada; Clement Echetebu; Christine Dettbarn; Philip Palade
Journal:  Biochem Biophys Res Commun       Date:  2002-08-16       Impact factor: 3.575

3.  Facilitation of murine cardiac L-type Ca(v)1.2 channel is modulated by calmodulin kinase II-dependent phosphorylation of S1512 and S1570.

Authors:  Anne Blaich; Andrea Welling; Stefanie Fischer; Jörg Werner Wegener; Katharina Köstner; Franz Hofmann; Sven Moosmang
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-17       Impact factor: 11.205

4.  Calcium oscillations and T-wave lability precede ventricular arrhythmias in acquired long QT type 2.

Authors:  Jan Němec; Jong J Kim; Beth Gabris; Guy Salama
Journal:  Heart Rhythm       Date:  2010-07-03       Impact factor: 6.343

Review 5.  Long QT syndrome: reduced repolarization reserve and the genetic link.

Authors:  D M Roden
Journal:  J Intern Med       Date:  2006-01       Impact factor: 8.989

Review 6.  Is gender a risk factor for adverse drug reactions? The example of drug-induced long QT syndrome.

Authors:  M D Drici; N Clément
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

7.  Repression of NFAT3 transcriptional activity by estrogen receptors.

Authors:  X Qin; X-H Wang; Z-H Yang; L-H Ding; X-J Xu; L Cheng; C Niu; H-W Sun; H Zhang; Q-N Ye
Journal:  Cell Mol Life Sci       Date:  2008-09       Impact factor: 9.261

8.  cAMP-dependent phosphorylation sites and macroscopic activity of recombinant cardiac L-type calcium channels.

Authors:  G Mikala; U Klöckner; M Varadi; J Eisfeld; A Schwartz; G Varadi
Journal:  Mol Cell Biochem       Date:  1998-08       Impact factor: 3.396

9.  Changes in ovarian oestrogens and in plasma gonadotrophins in female rabbits from birth to adulthood.

Authors:  M de Turckheim; M Berger; C Jean-Faucher; G Veyssière; C Jean
Journal:  Acta Endocrinol (Copenh)       Date:  1983-05

Review 10.  ICI 182,780 (Fulvestrant)--the first oestrogen receptor down-regulator--current clinical data.

Authors:  J F Robertson
Journal:  Br J Cancer       Date:  2001-11       Impact factor: 7.640

View more
  19 in total

1.  Synchronous systolic subcellular Ca2+-elevations underlie ventricular arrhythmia in drug-induced long QT type 2.

Authors:  Jong J Kim; Jan Němec; Qiao Li; Guy Salama
Journal:  Circ Arrhythm Electrophysiol       Date:  2015-02-26

Review 2.  How do sex hormones modify arrhythmogenesis in long QT syndrome? Sex hormone effects on arrhythmogenic substrate and triggered activity.

Authors:  Katja E Odening; Gideon Koren
Journal:  Heart Rhythm       Date:  2014-06-19       Impact factor: 6.343

3.  Spontaneous initiation of premature ventricular complexes and arrhythmias in type 2 long QT syndrome.

Authors:  Xiaodong Huang; Tae Yun Kim; Gideon Koren; Bum-Rak Choi; Zhilin Qu
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-10-07       Impact factor: 4.733

4.  Cross-sex hormonal replacement: is this really effective? an experimental clue.

Authors:  Natalia Pavón; Israel Pérez-Torres; Alberto Aranda; Francisco-Javier Roldán; Cristina Paredes; Edmundo Chávez
Journal:  Endocrine       Date:  2013-02-26       Impact factor: 3.633

5.  Bradycardia alters Ca(2+) dynamics enhancing dispersion of repolarization and arrhythmia risk.

Authors:  Jong J Kim; Jan Němec; Rita Papp; Robert Strongin; Jonathan J Abramson; Guy Salama
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-01-11       Impact factor: 4.733

Review 6.  The link between abnormal calcium handling and electrical instability in acquired long QT syndrome--Does calcium precipitate arrhythmic storms?

Authors:  Jan Němec; Jong J Kim; Guy Salama
Journal:  Prog Biophys Mol Biol       Date:  2015-11-26       Impact factor: 3.667

Review 7.  Sex differences in the mechanisms underlying long QT syndrome.

Authors:  Guy Salama; Glenna C L Bett
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-06-27       Impact factor: 4.733

Review 8.  Arrhythmic risk during pregnancy and postpartum in patients with long QT syndrome.

Authors:  Babken Asatryan; Marina Rieder; Alessandro Castiglione; Katja E Odening
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2021-03-29

9.  Spectrum of Cav1.4 dysfunction in congenital stationary night blindness type 2.

Authors:  Verena Burtscher; Klaus Schicker; Elena Novikova; Birgit Pöhn; Thomas Stockner; Christof Kugler; Anamika Singh; Christina Zeitz; Marie-Elise Lancelot; Isabelle Audo; Bart Peter Leroy; Michael Freissmuth; Stefan Herzig; Jan Matthes; Alexandra Koschak
Journal:  Biochim Biophys Acta       Date:  2014-05-04

10.  In silico Prediction of Sex-Based Differences in Human Susceptibility to Cardiac Ventricular Tachyarrhythmias.

Authors:  Pei-Chi Yang; Colleen E Clancy
Journal:  Front Physiol       Date:  2012-09-14       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.